Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Raydiant Oximetry
AddedFeb 15, 2024
UpdatedJun 18, 2026
Raydiant Oximetry

Raydiant Oximetry

Series A

Raydiant Oximetry provides non-invasive biomedical devices for monitoring babies' oxygenation during pregnancy.

HQ
Mountain View, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Raydiant Oximetry, Inc. operates as a medical device company. The Company develops and distributes a non-invasive technology that directly monitors a babies' oxygenation during pregnancy.

Raydiant Oximetry serves customers in the State of California.

Raydiant Oximetry - Similar Companies

Noninvasix logo

Noninvasix

noninvasix.com

Rapid Oxygen logo

Rapid Oxygen

rapidoxygen.com

Masimo logo

Masimo

masimo.com

ViOptix logo

ViOptix

vioptix.com

Opticyte logo

Opticyte

opticyte.com

Bioxytech Retina logo

Bioxytech Retina

bioxytech.com

Babyscripts logo

Babyscripts

babyscripts.com

Cercacor Laboratories logo

Cercacor Laboratories

cercacor.com

Owlet logo

Owlet

owletcare.com

Respirix logo

Respirix

Cardiox logo

Cardiox

cardiox.com

OxiWear logo

OxiWear

oxiwear.com

Vital Metrix logo

Vital Metrix

PyrAmes logo

PyrAmes

pyrameshealth.com

Noninvasive Medical Technologies logo

Noninvasive Medical Technologies

nmtinc.org

Raydiant Oximetry - Quick Facts

Who are Raydiant Oximetry's competitors?

Companies similar to Raydiant Oximetry include Noninvasix, Rapid Oxygen, Masimo and ViOptix.

When was Raydiant Oximetry founded?

Raydiant Oximetry was founded in 2016.

Where is Raydiant Oximetry's headquarters located?

Raydiant Oximetry's headquarters is located in Mountain View, CA, US.

When was Raydiant Oximetry's last funding round?

Raydiant Oximetry's most recent funding round was for $5M (USD) in November 2021.

How much has Raydiant Oximetry raised to-date?

As of Nov 1, 2021, Raydiant Oximetry has raised a total of $18.1M (USD).

How many employees does Raydiant Oximetry have?

Raydiant Oximetry has 16 employees as of Feb 5, 2024.

Raydiant Oximetry - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified